U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C9H13N5O
Molecular Weight 207.2324
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of ICI-63197

SMILES

CCCN1C2=NC(N)=NN2C=C(C)C1=O

InChI

InChIKey=UQDVRVNMIJAGRK-UHFFFAOYSA-N
InChI=1S/C9H13N5O/c1-3-4-13-7(15)6(2)5-14-9(13)11-8(10)12-14/h5H,3-4H2,1-2H3,(H2,10,12)

HIDE SMILES / InChI

Molecular Formula C9H13N5O
Molecular Weight 207.2324
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Description
Curator's Comment: The description was created based on several sources, including https://www.ncbi.nlm.nih.gov/pubmed/189873 | https://www.ncbi.nlm.nih.gov/pubmed/15019272

ICI-63197 is a potent and selective phosphodiesterase IV (PDE 4) inhibitor with potent antidepressant activity. The antidepressant action of ICI-63197 realizes via enhancement of central noradrenergic transmission due to selective inhibition of cAMP phosphodiesterase. ICI 63 197 was investigated in mice for its effectiveness in two classical test models for prediction of clinical antidepressant activity: antagonism of reserpine-induced hypothermia or hypokinesia and potentiation of yohimbine lethality. ICI 63 197 was approximately 15 times more potent than imipramine in antagonizing reserpine-induced hypothermia. The antihypothermic effect of the ICI-63197 occurred at a smaller dose than that of imipramine. In contrast to imipramine, the ICI-63197 reversed reserpine-induced hypokinesia. ICI-63197 approximately, as potent as imipramine in potentiating the lethality of yohimbine. ICI 63 197 was never tested in clinical trials.

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Primary
Unknown

Approved Use

Unknown
Primary
Unknown

Approved Use

Unknown
PubMed

PubMed

TitleDatePubMed
Potential antidepressant activity of rolipram and other selective cyclic adenosine 3',5'-monophosphate phosphodiesterase inhibitors.
1983 Mar
Patents

Patents

Sample Use Guides

0.48-29.9 mkM/kg (Male NMRI mic)
Route of Administration: Intraperitoneal
In Vitro Use Guide
The rate of acid secretion and mucosal cyclic adenosine 3',5'-monophosphate (cyclic AMP) content have been measured on the same guinea-pig isolated stomach preparation in response to ICI 63197, a potent phosphodiesterase inhibitor. The stomach was divided into two halves along the greater curvature and each half was tied over the end of a short perspex tube, mucosal surface facing the lumen. The muscle coat was not removed. The serosal surface was bathed with a bicarbonate buffered saline and gassed with 95% 2 and 5% CO2 whilst the mucosal surface was bathed with a similar but unbuffered saline gassed with 100% O2. The volume of serosal bathing fluid was 30 ml and the rate of acid secretion was determined by titration with 20 mM NaOH. Following dissection, the preparations were set up in the tissue bath and gassed for 1 h before addition of ICI-63197. The mucosal saline was changed every 15 min and the rate of spontaneous acid secretion determined. After the addition of drug (ICI-63197), acid secretion was measured for four further 15 min periods. The rate associated with the drug was taken as the average of the last two such periods. Tissues were then taken from the bath and placed in ice cold saline before extraction for cyclic AMP assay.
Substance Class Chemical
Created
by admin
on Sat Dec 16 11:01:18 GMT 2023
Edited
by admin
on Sat Dec 16 11:01:18 GMT 2023
Record UNII
015G4I43YD
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
ICI-63197
Common Name English
ICI 63,197
Code English
PP-769
Code English
ICI-63,197
Code English
(1,2,4)TRIAZOLO(1,5-A)PYRIMIDIN-5(4H)-ONE, 2-AMINO-6-METHYL-4-PROPYL-
Systematic Name English
2-AMINO-6-METHYL-4-PROPYL-1,2,4-TRIAZOLO(1,5-A)PYRIMIDIN-5(4H)-ONE
Systematic Name English
Code System Code Type Description
WIKIPEDIA
ICI-63197
Created by admin on Sat Dec 16 11:01:18 GMT 2023 , Edited by admin on Sat Dec 16 11:01:18 GMT 2023
PRIMARY
CAS
27277-00-5
Created by admin on Sat Dec 16 11:01:18 GMT 2023 , Edited by admin on Sat Dec 16 11:01:18 GMT 2023
PRIMARY
EPA CompTox
DTXSID6041391
Created by admin on Sat Dec 16 11:01:18 GMT 2023 , Edited by admin on Sat Dec 16 11:01:18 GMT 2023
PRIMARY
ECHA (EC/EINECS)
248-383-5
Created by admin on Sat Dec 16 11:01:18 GMT 2023 , Edited by admin on Sat Dec 16 11:01:18 GMT 2023
PRIMARY
PUBCHEM
62824
Created by admin on Sat Dec 16 11:01:18 GMT 2023 , Edited by admin on Sat Dec 16 11:01:18 GMT 2023
PRIMARY
FDA UNII
015G4I43YD
Created by admin on Sat Dec 16 11:01:18 GMT 2023 , Edited by admin on Sat Dec 16 11:01:18 GMT 2023
PRIMARY
Related Record Type Details
ACTIVE MOIETY